# Immunai funding: rounds and investors

> Immunai has raised $215M across 1 round since 2021. Investors include 8VC, Alexandria Venture Investments and Catalio Capital Management.

Source: https://millionrounds.com/company/immunai (Millionrounds; every figure on the page links to its filing or article)

United States · [Series B startup](https://millionrounds.com/companies)

# Who invested in *Immunai*

One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Big Data & Analytics

Valuation: $1.0B, Oct 2024

Funding summary Updated 26 Oct 2026

**$215M** raised across 1 round since 2021, from 1 source

- **Latest round:** Series B, $215M Oct 2021
- **Investors:** 4

See who backed them

## The rounds

- **Oct 2021** Series B **$215M** [8VC](https://millionrounds.com/fund/8vc) [Alexandria Venture Investments](https://millionrounds.com/fund/alexandria-venture-investments) [Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) TLV Partners Source recorded

## Everyone who backed them

[8VC](https://millionrounds.com/fund/8vc) VC firm **1** round

[Alexandria Venture Investments](https://millionrounds.com/fund/alexandria-venture-investments) VC firm **1** round

[Catalio Capital Management](https://millionrounds.com/fund/catalio-capital-management) VC firm **1** round

TLV Partners no record of our own yet **1** round

Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=immunai).

## Also claim to have backed them

These 2 firms list Immunai as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

[Piedmont Capital Investments](https://millionrounds.com/fund/piedmont-capital-investments) VC firm Per its own site

[SIB Investment Group](https://millionrounds.com/fund/sib-investment-group) Family office Per its own site

## Quick answers about Immunai

### Who invested in Immunai?

Immunai's investors include 8VC, Alexandria Venture Investments, Catalio Capital Management and TLV Partners.

### How much has Immunai raised?

Immunai has raised $215M across 1 round since 2021.

### When did Immunai last raise?

Immunai's most recent round was a Series B of $215M in Oct 2021.

### What was Immunai's biggest round?

Its most recent round, $215M in Oct 2021, is also its largest on record.

### Who backed Immunai first?

Immunai's first round on record, in Oct 2021, was backed by 8VC, Alexandria Venture Investments and Catalio Capital Management and 1 others.

### What stage is Immunai at?

Immunai's latest named round is a Series B, in Oct 2021.

### Where is Immunai based?

Immunai is based in the United States.

## Companies like Immunai

In the same sector, and raised in the last eighteen months.

[**SpaceX** $42B · Oct 2026](https://millionrounds.com/company/spacex)[**STRIVE** $1.3B · Oct 2026](https://millionrounds.com/company/strive)[**Xona** $512M · Oct 2026](https://millionrounds.com/company/xona)[**DrizzleX** $9.1M · Oct 2026](https://millionrounds.com/company/drizzlex)[**Prism Data** $25M · Oct 2026](https://millionrounds.com/company/prism-data)[**Homa** $5.0M · Oct 2026](https://millionrounds.com/company/homa)

## Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app